BioSpace News Archive

Outlook Therapeutics, Inc. announced that Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics, will be presenting at the Wet AMD and DME Drug Development Summit taking place April 5-7, 2022 in Boston, Massachusetts.

Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, announced that management will be taking part in the following conferences in April.

Humacyte, Inc. today announced the appointment of Shamik J. Parikh, M.D., as Chief Medical Officer.

Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that two of its newly designed mRNA molecules are effective at destroying cancer cells grown in culture.

Sema4 (Nasdaq: SMFR), an artificial intelligence (AI)-driven genomic and clinical data intelligence platform company, and researchers from the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York, NY recently published a study in Nature Communications using network modeling to identify novel targets for treating patients with early-stage invasive lung adenocarcinoma.

iCAD, Inc. announced that additional patients have been treated under the international multi-center GLIOX trial and customers globally are continuing to expand use of intraoperative radiation therapy for the treatment of multiple tumor types, including brain, rectal, and head and neck cancers using the Xoft® Electronic Brachytherapy System®.

Mission Bio, Inc. today announced the appointment of Todd Druley , MD, PhD.

Aldeyra Therapeutics, Inc. today announced completion of enrollment in the Phase 3 TRANQUILITY-2 Trial of 0.25% reproxalap ophthalmic solution (reproxalap) in patients with dry eye disease.

Thermo Fisher Scientific Launches User-Friendly Raman Spectroscopic Analyzer.

Apnimed announced that company management will participate in 1x1 investor meetings at the 21st Needham Healthcare Conference taking place virtually April 11-14, 2022.